Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
₹ 256000 / 2000 Shares Shares
Minimum Investment
Curis Lifesciences Limited IPO
Issues Price
₹120-128 per equity share
Curis Lifesciences Limited IPO
Open Date
07 Nov 2025
Close Date
11 Nov 2025
Lot Size
1000
Min. Investment
₹ 256000
Issue Price
₹120-128
Listing Date
14 Nov 2025
Issues Size
21,50,000 shares(aggregating up to ₹27.52 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
2000 Shares
Offered To Public
2000 Shares
Curis Lifesciences Limited IPO
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Founded In
2020
Managing Director
Dharmesh Dasharathbhai Patel
Parent Organization
Curis Lifesciences Limited IPO
Application for Curis Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹120-128 | ₹2,56,000 |
| Individual(max) | ₹120-128 | ₹2,56,000 |
| SHNI(min) | ₹120-128 | ₹3,84,000 |
| SHNI(max) | ₹120-128 | ₹8,96,000 |
| BHNI(min) | ₹120-128 | ₹10,24,000 |
Apply for all eligible candidates, Curis Lifesciences Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
KSquare’s service was fast, transparent, and easy to follow. Perfect for someone like me who needed quick access to funds.
KSquare offered me a quick solution when I needed funds. They made the loan process easy to understand and access.
It’s rare to find an investing service that explains NFOs in such a relatable way. KSquare really bridges that gap. Very impressed!
KSquare helped me choose the right pension fund with detailed comparisons. Their expert team made everything clear.
Being self-employed, I wanted a structured way to invest. KSquare’s SIPs fit the bill. It’s affordable, effective, and easy to track progress over time.
I’ve tested many platforms, but KSquare stands out for their transparency and consistent performance. SIPs with them feel like a smart, hassle-free decision.
KSquare’s mutual fund platform is exactly what I needed. It’s intuitive, offers diverse funds, and gives great insights. I’ve seen real growth since I started.
The way KSquare introduces New Fund Offerings is so clear and informative. I’ve been able to diversify with great timing and zero confusion.
I was skeptical about loans on mutual funds, but KSquare provided full clarity and fast execution. Loved the experience!
I appreciate the balance of automation and control KSquare gives. Their fund research and regular updates give me confidence in every investment decision I make.
FAQ's
Frequenlty Asked Question
What types of mutual funds are available on KSquare?
KSquare offers equity, debt, hybrid, ELSS, and index funds to suit different financial goals and risk profiles.
What is the role of the AMC in a New Fund Offering?
The Asset Management Company (AMC) designs and manages the NFO, ensuring strategy alignment and regulatory compliance.
What is the ideal duration for a SIP investment?
The longer the duration, the better the returns. Ideally, stay invested for at least 5–10 years for best results.
Do SIPs guarantee returns?
No, SIPs don’t guarantee returns but reduce risk over time and provide the potential for solid, market-linked growth.
Will I get tax benefits through SIP investments?
Yes, SIPs in ELSS funds qualify for tax deductions under Section 80C up to ₹1.5 lakh annually.
When do NFO units get credited to my account?
Units are credited within a few days after the NFO closes and the scheme is processed by the fund house.
What is the difference between SIP and lump sum in mutual funds?
SIP involves regular, small investments over time, while lump sum is a one-time larger investment. SIP is better for market averaging.
Is NPS a good option for retirement planning?
Yes, NPS offers disciplined savings, market-linked returns, and tax benefits, making it a strong choice for long-term retirement planning.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.